2022
DOI: 10.1016/j.xcrm.2022.100517
|View full text |Cite
|
Sign up to set email alerts
|

Medicine as constraint: Assessing the barriers to gender-affirming care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 11 publications
(25 reference statements)
0
5
0
1
Order By: Relevance
“…Despite the diagnostic criteria being updated to be more culturally sensitive, the mere inclusion of gender dysphoria in the DSM has been equated to pathologization and has been a source of great controversy between transgender communities, activists, and psychological and medical communities (Davy & Toze, 2018). One of the main arguments for keeping gender dysphoria within the DSM is that diagnosis hypothetically increases access to medical gender-affirming procedures (Kumar et al, 2022). However, this process has created a system of gatekeeping, requiring transgender people to provide evidence of gender transition readiness from their mental and health care providers in most jurisdictions (Davy & Toze, 2018).…”
Section: Pathologization and Gatekeepingmentioning
confidence: 99%
“…Despite the diagnostic criteria being updated to be more culturally sensitive, the mere inclusion of gender dysphoria in the DSM has been equated to pathologization and has been a source of great controversy between transgender communities, activists, and psychological and medical communities (Davy & Toze, 2018). One of the main arguments for keeping gender dysphoria within the DSM is that diagnosis hypothetically increases access to medical gender-affirming procedures (Kumar et al, 2022). However, this process has created a system of gatekeeping, requiring transgender people to provide evidence of gender transition readiness from their mental and health care providers in most jurisdictions (Davy & Toze, 2018).…”
Section: Pathologization and Gatekeepingmentioning
confidence: 99%
“…Current treatment standards suggest that adults starting hormone therapy meet the following criteria: persistent/consistent gender identity, capacity to consent to treatment, and that mental or physical health concerns are assessed and included in the discussion of risks and benefits [ 27 , 28 ]. This shift away from previous language in recommendations which required “reasonable” control of mental illness is notable, as historically gender-affirming care has been denied or delayed due to the presence of other psychiatric diagnoses [ 38 ]. However, new guidelines place the focus on reducing the barriers the psychiatric illness may place on accessing and engaging in gender affirming treatment [ 27 ].…”
Section: Hormonal Treatmentsmentioning
confidence: 99%
“…Further, VHA has implemented and nationally disseminated programs aimed specifically at improving the health of LGBTQ+ veterans, 18 such as expanding coverage of gender affirming care, 19 designation of an LGBTQ+ Veteran Care Coordinator at every VHA facility, 20 and provider trainings 20,21 . In contrast, policies of other public insurance programs, such as Medicare/Medicaid, may increase barriers to coverage of gender affirming care, in particular 22,23 …”
Section: Introductionmentioning
confidence: 99%
“…20,21 In contrast, policies of other public insurance programs, such as Medicare/Medicaid, may increase barriers to coverage of gender affirming care, in particular. 22,23 However, studies have found that LGBTQ+ veterans experience dissatisfaction with VHA care, including concerns about safety, stigma, and discrimination. [24][25][26] For instance, LGBTQ+ women veterans report greater harassment at VHA and are more likely to miss an appointment due to concerns about the environment compared to non-LGBTQ+ women veterans.…”
Section: Introductionmentioning
confidence: 99%